Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Shandong Xinhua Pharmaceutical Company Limited
- Max Healthcare
Comparative performance (base 100)
Each asset is worth 100 at October 20, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Each performance is calculated in the asset's trading currency, without currency conversion.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | Shandong Xinhua Pharmaceutical Company LimitedStock | Max HealthcareStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | −25.1% | −30.1% |
| Annualized performanceAverage annual return that would produce the same total performance. | −25.4% | −30.4% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 32.9% | 26.8% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −26.7% | −30.1% |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | -0.85 | -1.30 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −2.8% | −3.0% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 3.83B HKD | 823.42B INR |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 15.7 | 56.7 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 0.5 | 9.5 |
| Net marginShare of revenue retained as profit. | 2.5% | 16.7% |
| Return on equityReturn on equity (ROE). | 4.1% | Unavailable |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | −12.4% | +16.7% |
| Dividend yieldAnnual dividend relative to the share price. | 3.14% | 0.24% |
| Debt / equityFinancial debt relative to shareholders' equity. | 26% | 32% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- Shandong Xinhua Pharmaceutical Company Limited / Max Healthcare-0.00
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.